UK Scientists Engineer Cell Membrane for Long-Lasting Cell Therapy
Scientists at the University of Bristol, UK, have made a cell therapy that produces a…
25/04/2019 - 3 minutes
Cell therapy
First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials
A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as…
15/04/2019 - 2 minutes
Chasing the Holy Grail of Cell Therapy
Biotech entrepreneur Darrin Disley, ex-CEO and co-founder of the successful Cambridge gene editing biotech Horizon…
01/04/2019 - 7 minutes
Microsoft Aims to Make Cell Therapies Cheaper with Artificial Intelligence
Microsoft has launched a collaboration with the UK company Oxford BioMedica to use Microsoft’s artificial…
14/03/2019 - 2 minutes
Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency
All 20 patients with a rare immunodeficiency disease survived for at least two years after…
25/02/2019 - 2 minutes
This Biotech’s Algorithm Accelerates Cell Therapy Development
Mogrify is the new kid on the block for cell therapy. Based in Cambridge, UK,…
22/02/2019 - 3 minutes
Looking Back on 2018: Our 10 Most Popular Interviews
As 2018 draws to a close and our thoughts are torn between holiday plans and…
24/12/2018 - 8 minutes
Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M
The UK company Synthace has raised €22.6M to develop its software platform to automate and…
17/12/2018 - 2 minutes
How Automation Will Enable the Age of Cell Therapy
Scientists in biotech and pharma spend more and more of their valuable time culturing cells…
05/12/2018 - 5 minutes
Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease
Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little…
07/11/2018 - 2 minutes
Cell Therapy Helps Regenerate Difficult Bone Fractures
All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen…
14/09/2018 - 2 minutes
Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease
The Israeli biotech Pluristem has Phase II data indicating that its cell therapy made of…
13/06/2018 - 2 minutes
